insights_auto
Why is 603259 up 10.00%?
Dive Deeperchevron_right
603259:SHA
WuXi AppTec Co Ltd
CN¥148.81
arrow_upward
+10.00%(+13.53) 1D
Nov 4, 3:00:02 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 603259...
Open
CN¥135.30
High
CN¥148.81
Low
CN¥134.08
Mkt. cap
415.33B
Avg. vol.
41.35M
Volume
56.90M
Dividend
1.40%
Quarterly dividend
CN¥0.52
Ex-dividend date
Sep 4, 2026
P/E ratio
16.70
52-wk high
CN¥173.60
52-wk low
CN¥87.09
EPS
CN¥8.91
Shares outstanding
1.05B
No. of employees
36K
Open
CN¥135.30
High
CN¥148.81
Low
CN¥134.08
Mkt. cap
415.33B
Avg. vol.
41.35M
Volume
56.90M
Dividend
1.40%
Quarterly dividend
CN¥0.52
Ex-dividend date
Sep 4, 2026
P/E ratio
16.70
52-wk high
CN¥173.60
52-wk low
CN¥87.09
EPS
CN¥8.91
Shares outstanding
1.05B
No. of employees
36K
News stories
From web sources and news partners
Moomoo
·
16 hours ago
Trending Industry Today: WUXI APPTEC Leads Gains In Biotechnology Stocks
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
About WuXi AppTec Co Ltd
CEOSteve Yang | Ge Li
Employees35.6K
FoundedDec 1, 2000
Headquarters-
SectorHealth care
Industry-
Websitewuxiapptec.com.cn